Lyratzopoulos, Georgios and Neal, Richard D. and Barbiere, Josephine M. and Rubin, Gregory P. and Abel, Gary A. (2012) 'Variation in number of general practitioner consultations before hospital referral for cancer : findings from the 2010 National Cancer Patient Experience Survey in England.', The Lancet oncology,, 13 (4). pp. 353-365.
Background: Information from patient surveys can help to identify patient groups and cancers with the greatest potential for improvement in the experience and timeliness of cancer diagnosis. We aimed to examine variation in the number of pre-referral consultations with a general practitioner between patients with different cancers and sociodemographic characteristics. Methods: We analysed data from 41 299 patients with 24 different cancers who took part in the 2010 National Cancer Patient Experience Survey in England. We examined variation in the number of general practitioner consultations with cancer symptoms before hospital referral to diagnose cancer. Logistic regression was used to identify independent predictors of three or more pre-referral consultations, adjusting for cancer type, age, sex, deprivation quintile, and ethnic group. Findings: We identified wide variation between cancer types in the proportion of patients who had visited their general practitioner three or more times before hospital referral (7·4% [625 of 8408] for breast cancer and 10·1% [113 of 1124] for melanoma; 41·3% [193 of 467] for pancreatic cancer and 50·6% [939 of 1854] for multiple myeloma). In multivariable analysis, with patients with rectal cancer as the reference group, those with subsequent diagnosis of multiple myeloma (odds ratio [OR] 3·42, 95% CI 3·01–3·90), pancreatic cancer (2·35, 1·91–2·88), stomach cancer (1·96, 1·65–2·34), and lung cancer (1·68, 1·48–1·90) were more likely to have had three or more pre-referral consultations; conversely patients with subsequent diagnosis of breast cancer (0·19; 0·17–0·22), melanoma (0·34, 0·27–0·43), testicular cancer (0·47, 0·33–0·67), and endometrial cancer (0·59, 0·49–0·71) were more likely to have been referred to hospital after only one or two consultations. The probability of three or more pre-referral consultations was greater in young patients (OR for patients aged 16–24 years vs 65–74 years 2·12, 95% CI 1·63–2·75; p<0·0001), those from ethnic minorities (OR for Asian vs white 1·73, 1·45–2·08; p<0·0001; OR for black vs white 1·83, 1·51–2·23; p<0·0001), and women (OR for women vs men 1·28, 1·21–1·36; p<0·0001). We identified strong evidence of interactions between cancer type and age group and sex (p<0·0001 for both), and between age and ethnicity (p=0·0013). The model including these interactions showed a particularly strong sex effect for bladder cancer (OR for women vs men 2·31, 95% CI 1·98–2·69) and no apparent ethnic group differences in young patients aged 16–24 years, whilst the only cancers without an apparent age gradient were testicular cancer and mesothelioma. Interpretation: Our findings could help to prioritise and stratify early diagnosis initiatives and research, focusing on patients with cancers and sociodemographic characteristics with the largest potential for improvement.
|Additional Information:||NOTE TO READERS – please read first This is a Word format post-print version of the full text article (PubMed record citation as of 3rd March 2012): Lyratzopoulos G, Neal RD, Barbiere JM, Rubin GP, Abel GA. Variation in number of general practitioner consultations before hospital referral for cancer: findings from the 2010 National Cancer Patient Experience Survey in England. Lancet Oncol. 2012 Feb 23. [Epub ahead of print] PMID:22365494 The online appendices of the above paper are also included in the Word format post-print. The article ‘as printed’ by the Lancet Oncology can be accessed via this linke (institutional subscription or pay-per-view may be required): http://www.lancet.com/journals/lanonc/article/PIIS1470-2045(12)70041-4/fulltext The ‘as printed’ full text article and its figures and tables are edited to high quality and we encourage readers to access our paper using the Lancet Oncology URL above wherever possible. NOTICE: this is the author’s version of a work that was accepted for publication in The Lancet oncology. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in The Lancet oncology, [13, 4, 2012] 10.1016/S1470-2045(12)70041-4|
|Full text:||PDF - Accepted Version (958Kb)|
|Publisher Web site:||http://dx.doi.org/10.1016/S1470-2045(12)70041-4|
|Record Created:||07 Mar 2012 09:50|
|Last Modified:||03 Apr 2012 16:32|
|Social bookmarking:||Export: EndNote, Zotero | BibTex|
|Usage statistics||Look up in GoogleScholar | Find in a UK Library|